Application of Hyaluronic Acid Sodium Salt and Vitamin C in the Therapy of Dogs with Hypertrophic Osteodystrophy
Open Access
|Jun 2013References
- 1. Aleksiewicz R.: Treatment of arthritis of various etiologies with the advancement of the use of glycosaminoglycans. Życie Wet 1988,233-236.
- 2. Bennett D.: Nutrition and bone disease in the dog and cat. Vet Rec 1976,313-321.
- 3. Boyan B.D., Schwartz Z., Swain L.D.: Matrix vesicles as a marker of endochondral ossification. Connect Tissue Res 1990,, 67-75.
- 4. Campo G.M., Avenoso A., Campo S., D'Ascola A., Ferlazzo A.M., Calatroni A.: Reduction of DNA fragmentation and hydroxyl radical production by hyaluronic acid and chondroitin-4-sulphate in iron plus ascorbate-induced oxidative stress in fibroblast cultures. Free Radic Res 2004,601-611.
- 5. Chow G., Knudson G.B., Homandberg G., Knudson W.: Increased expression of CD44 in bovine articular chondrocytes by catabolic cellular mediators. J Biol Chem 1995,27734-27741.
- 6. Day A.J., De la Motte C.A.: Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 2005,637-643.
- 7. Evanko S.P., Tammi M.I., Tammi R.H., Wight T.N.: Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 2007,1351-1365.
- 8. Franklin M.A., Rochat M.C., Broaddus K.D.: Hypertrophic osteodystrophy of the proximal humerus in two dogs. J Am Anim Hosp Assoc 2008,342-346.
- 9. Giusti A., Hamdy N.A., Papapoulos S.E.: Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case/case series studies. Bone 2010,7, 169-180.
- 10. Goodman S.A., Montgomery R.D., Fitch R.B., Hathcock J.T., Lauten S.D., Cox N.R., Kincaid S.A., Rumph P.F., Brawnwer W.R., Baker H.J., Lepine A.L., Reinhart G.A.: Serial orthopedic examinations of growing Great Dane puppies fed three diets varying in calcium and phosphorus. In:Orange Frazer Press-Ohio, 1988, pp. 3-12.
- 11. Harrus S., Waner T., Aizenberg J., Safra N., Mosenco A., Radoshitsky M., Bark H.: Development of Hypertrophic osteodystrophy and antibody response in a litter of vaccinated Weimaraner puppies. J Small Anim Pract 2002,27-31.
- 12. Joiner K.S., Montgomery R.D.: Pathology in practice. Hypertrophic osteodystrophy. J Am Vet Med Assoc 2011,1413-1415.
- 13. Julovi S.M., Yasuda T., Shimizu M., Hiramitsu T., Nakamura T.: Inhibition of interleukin-1β-stimulated production of matrix metalloproteinases by hyaluronanCD44 in human articular cartilage. Arthritis Rheum 2004,, 516-525.
- 14. Kleczkowski M., Kluciński W., Sikora J.: Role of selected minerals in the oxidative processes of the body. Med Weter 2004,242-245.
- 15. Koper S., Komsta R.: Hypertrophic osteodystrophy (HOD) in dogs - a retrospective study. Mag Wet 2000,6-11.
- 16. Kucharz E.J.: The collagens: biochemistry and pathophysiology. Berlin-New York, Springer Verlag. 1992.
- 17. Laurent T.C., Fraser J.R.: Hyaluronan. FASEB J 1992,2397-2404.
- 18. Morgan J.P.: Radiology of Veterinary Orthopedics Features of Diagnosis. Venture Press, Napa, California, 1999.
- 19. Nakatani S., Mano H., Ryanghyok I.M., Shimizu J., Wada M.: Excess magnesium inhibits excess calciuminduced matrix-mineralization and production of matrix gla protein (MGP) by ATDC5 cells. Biochem Biophys Res Commun 2006,1157-1162.
- 20. Olsson S.E.: General and local etiologic factors in canine osteochondrosis. Vet Quart 1987,, 255-257.
- 21. Olsson S.E.: Osteochondrosis a growing problem to dog breeders. Gaines Dog Res Center 1976,4- 11.
- 22. Olsson S.E.: Radiology in veterinary pathology. Acta Radiol Suppl 1972,255-270.
- 23. Ozer K., Altunatmaz K., Gülcubuk A.: Hypertrophic osteodystrophy in the dog: 18 cases. Turk J Vet Anim Sci 2004,, 761-768.
- 24. Robey P.G., Boskey A.L.: The biochemistry of bone. In:Academic Press, New York, 1995, pp. 95-183.
- 25. Slevin M., Kumar G., Gaffney J.: Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002,41046-41059.
- 26. Šoltés L., Mendichi R., Kogan G., Schiller J., Stankovská M., Arnhold J.: Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules 2006,, 659-668.
- 27. Stanisz A.: Przystępny kurs statystyki w oparciu o program Statistica PL. StatSoft Polska, Kraków, 1998, p. 362.
- 28. Si-Kwang L.: Metabolic disease in animals. Semin Musculoskelet Radiol 2002,341-346.
- 29. Teare J.A., Krook L., Kallfelz F.A., Hintz H.F.: Ascorbic acid deficiency and hypertrophic osteodystrophy in the dog: a rebuttal. Cornell Vet 1976,384-401.
- 30. Trostel C.T., Pool R.R., McLaughlin R.M.: Canine lameness caused by development of orthopedic diseases: panosteitis, Legg-Calve-Perthes Disease, and hypertrophic osteodystrophy. Compend Cont Educ Pract Vet 2003,282-292.
- 31. Wang C.T., Lin Y.T., Chiang B.L., Lin Y.H., Hou S.M.: High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthr Cartil 2006,1237-1247.
- 32. Wentzell M.L.: Hypertrophic osteodystrophy preceding canine juvenile cellulitis in an Australian shepherd puppy. Can Vet J 2011,431-434.
- 33. Vuorio E., de Crombrugghe B.: The family of collagen genes. Ann Rev Biochem 1990,837-872.
- 34. Zou L., Zou X., Chen L., Li H., Mygind T., Kassem M., Bünger C.: Effect of hyaluronan on osteogenic differentiation of porcine bone marrow stromal cells. J Orthop Res 2008,713-720.
DOI: https://doi.org/10.2478/bvip-2013-0044 | Journal eISSN: 2450-8608 (formerly 2300-3235)
Language: English
Page range: 249 - 255
Published on: Jun 21, 2013
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2013 Roman Aleksiewicz, Krzysztof Lutnicki, Renata Komsta, Krzysztof Kostro, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons License.